Literature DB >> 15478027

Chronic recurrent multifocal osteomyelitis.

Anne Grethe Jurik1.   

Abstract

Chronic recurrent multifocal osteomyelitis (CRMO) is a clinical entity distinct from bacterial osteomyelitis. It occurs mainly in children and adolescents and is characterized by a prolonged, fluctuating course with recurrent episodes of pain occurring over several years. CRMO is often multifocal and most often seen in tubular bones, the clavicle, and less frequently the spine and pelvic bones; other locations are rare. The radiographic appearance suggests subacute or chronic osteomyelitis. Histopathological and laboratory findings are nonspecific and bacterial culture is usually negative. CRMO is often diagnosed by exclusion of the two main differential diagnoses--bacterial infections and tumor--by assessing for a characteristic course and the findings by conventional radiography, if necessary supplemented by scintigraphy and/or magnetic resonance imaging (MRI). The MRI appearance of CRMO lesions in tubular bones and the spine is often rather characteristic and support the diagnosis. It is important to diagnose CRMO to avoid unnecessary diagnostic procedures and initiate an appropriate therapy. Copyright 2004 Thieme Medical Publishers, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15478027     DOI: 10.1055/s-2004-835364

Source DB:  PubMed          Journal:  Semin Musculoskelet Radiol        ISSN: 1089-7860            Impact factor:   1.777


  28 in total

1.  A 16-year-old boy with multifocal, painless osseous lesions.

Authors:  Ellen M Dean; James C Wittig; Camilo Vilalobos; Roberto A Garcia
Journal:  Clin Orthop Relat Res       Date:  2012-04-28       Impact factor: 4.176

2.  Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate.

Authors:  Toni Hospach; Micha Langendoerfer; Tekla von Kalle; Jan Maier; Guenther E Dannecker
Journal:  Eur J Pediatr       Date:  2010-03-27       Impact factor: 3.183

3.  A potential new target for autoinflammatory bone disease.

Authors:  Elizabeth L Hartland
Journal:  J Biol Chem       Date:  2020-03-13       Impact factor: 5.157

4.  Pilot study: possible association of IL10 promoter polymorphisms with CRMO.

Authors:  J Hamel; D Paul; M Gahr; C M Hedrich
Journal:  Rheumatol Int       Date:  2011-01-15       Impact factor: 2.631

5.  Paediatric chronic recurrent multifocal osteomyelitis.

Authors:  Davy R Wong; Geoffrey R Wong; Bishoy Moussa; Megan T Ang
Journal:  BMJ Case Rep       Date:  2017-03-09

Review 6.  New discoveries in CRMO: IL-1β, the neutrophil, and the microbiome implicated in disease pathogenesis in Pstpip2-deficient mice.

Authors:  Polly J Ferguson; Ronald M Laxer
Journal:  Semin Immunopathol       Date:  2015-04-17       Impact factor: 9.623

7.  Autoinflammatory diseases in childhood, part 2: polygenic syndromes.

Authors:  María Navallas; Emilio J Inarejos Clemente; Estíbaliz Iglesias; Mónica Rebollo-Polo; Joan Calzada Hernández; Oscar M Navarro
Journal:  Pediatr Radiol       Date:  2020-02-17

8.  Whole-body MRI in patients with Non-bacterial Osteitis: Radiological findings and correlation with clinical data.

Authors:  A P Arnoldi; C L Schlett; H Douis; L L Geyer; A M Voit; F Bleisteiner; A F Jansson; S Weckbach
Journal:  Eur Radiol       Date:  2016-09-23       Impact factor: 5.315

9.  Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice.

Authors:  Violeta Chitu; Polly J Ferguson; Rosalie de Bruijn; Annette J Schlueter; Luis A Ochoa; Thomas J Waldschmidt; Yee-Guide Yeung; E Richard Stanley
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

10.  Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO).

Authors:  Paivi Mh Miettunen; Xingchang Wei; Deepak Kaura; Walid Abou Reslan; Alberto Nettel Aguirre; James D Kellner
Journal:  Pediatr Rheumatol Online J       Date:  2009-01-12       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.